Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orion Bags Another Big Pharma Partner With Merck & Co Prostate Cancer Deal

Raises Outlook After Pact For ODM-208

Jul 13 2022

• By Kevin Grogan

Orion — • Source: Orion

Related Content

Bayer's Faith In Pharma Pipeline Paying Off

Feb 21 2022

Data PROpel Lynparza To Potential Prostate Cancer Megablockbuster

Sep 24 2021

Orion Exits Neuro To Concentrate On Cancer And Pain

Mar 24 2022

Rare Setback For Merck & Co And AstraZeneca’s Keytruda-Lynparza Combo In Prostate Cancer

Mar 16 2022

Merck & Co Closing In On Seagen Acquisition

Jul 08 2022

AstraZeneca/Merck Reinforce Lynparza’s Prostate Cancer Position With First-Line Data

Jun 21 2022

Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners

May 02 2022

Related Companies

Bayer AG

Orion

Merck & Co., Inc.

AstraZeneca PLC

Johnson & Johnson

Pfizer Inc.

Astellas Pharma, Inc.

Seagen Inc.

Gilead Sciences, Inc.

Dragonfly Therapeutics, Inc.

Additional Topics

Deals Companies Commercial Business Strategies Cancer BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window